Home
About
Overview
Sharing Data
ORCID
Help
History (43)
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals.
Management strategies for relapsed/refractory multiple myeloma: current clinical perspectives.
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype.
See All 43 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype.
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res. 1983 Oct 25; 11(20):7191-203.
View in:
PubMed
subject areas
Antigens, Viral
Base Sequence
Biological Evolution
Hemagglutination, Viral
Hemagglutinins, Viral
Influenza A virus
Influenza A Virus, H1N1 Subtype
RNA, Viral
Species Specificity
Virion
authors with profiles
Susannah Spiess
Nancy Jean Cox